Summary Long-Term Outcome of 106 Consecutive Pediatric Ruptured Brain Arteriovenous Malformations After Combined Treatment | Stroke www.ahajournals.org
11,582 words - html page - View html page
One Line
This study investigated the lasting effects of combined treatment on 106 pediatric patients with ruptured brain arteriovenous malformations, aiming to halt bleeding and remove the nidus.
Slides
Slide Presentation (10 slides)
Key Points
- The long-term outcome of 106 pediatric patients with ruptured brain arteriovenous malformations (AVMs) after combined treatment was studied.
- The overall survival rate was 92.5%.
- The annual bleeding rate was 2.71%.
- The endovascular treatment aimed to eliminate the source of bleeding and obliterate the nid.
- The overall obliteration rate after combined treatment was 61.2%.
- The risk of hemorrhage decreased significantly after treatment.
- There was a recurrence rate of 1 case out of 106 patients, 9 years after complete surgical treatment.
- The risk of rebleeding after stereotactic radiosurgery for hemorrhagic AVMs is discussed.
Summaries
30 word summary
This study examined the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (bAVMs) after combined treatment. The treatment aimed to stop the bleeding and eliminate the nidus.
35 word summary
This study focused on the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (bAVMs) after combined treatment. The goal of treatment was to eliminate the source of bleeding and obliterate the nidus
501 word summary
The long-term outcome of 106 pediatric patients with ruptured brain arteriovenous malformations (AVMs) after combined treatment was studied. The study found that the overall survival rate was 92.5% and the AVM obliteration
This study examines the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (bAVMs) after combined treatment. The study found that the annual bleeding rate was 2.71%, with a higher rate
This study aims to assess the clinical and angiographic outcome of combined treatment for pediatric brain arteriovenous malformations (bAVMs). The study includes a longitudinal cohort of consecutive patients referred to Necker Enfants Malades Hospital between January
The study focused on the long-term outcome of 106 pediatric patients with ruptured brain arteriovenous malformations (bAVMs) after combined treatment. The endovascular treatment aimed to eliminate the source of bleeding and obliterate the nid
A total of 106 pediatric patients with ruptured brain arteriovenous malformations (AVMs) were studied. Most patients were male (58.5%) and had a mean age of 116.5 months. Hemorrhage was
The overall obliteration rate for pediatric ruptured brain arteriovenous malformations (AVMs) after combined treatment was 61.2%. Some patients were still waiting for obliteration, while others had died or were lost to follow-up.
A study examined the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (bAVMs) who received combined treatment. The goal of treatment was to preserve neurological function and prevent secondary intracerebral hemorrh
A study on the long-term outcome of pediatric ruptured brain arteriovenous malformations (bAVMs) found a recurrence rate of 1 case out of 106 patients, 9 years after complete surgical treatment. The study also noted
This summary is a collection of references to various studies and articles related to the long-term outcome of pediatric ruptured brain arteriovenous malformations (AVMs) after combined treatment. The studies discuss predictors of hemorrhage in untreated brain AVM
This study examined the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (AVMs) after combined treatment. The study found that the risk of hemorrhage in these patients decreased significantly after treatment. However,
The article discusses the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (AVMs) after combined treatment. The risk of rebleeding after stereotactic radiosurgery for hemorrhagic AVMs is
This document is a compilation of various studies and articles related to the long-term outcome and treatment of pediatric brain arteriovenous malformations (AVMs). The studies cover topics such as the use of medical adjuvants, early outcomes and
The American Heart Association is a qualified tax-exempt organization. They use cookies and similar technologies to enhance website functionality and personalize content. Users can manage their cookie preferences.
This excerpt is not part of the main article and does not contain any important details or key points. It is a privacy and cookie notice that provides information about managing cookie preferences on a website.
The study examined the long-term outcomes of 106 pediatric patients with ruptured brain arteriovenous malformations (AVMs) after combined treatment. The results showed that the overall survival rate was 91.5% and the cumulative rate of